BIFILAC Dry Syrup

BIFILAC Dry Syrup

BIFILAC-Dry-Syrup-abpl
Manufacturer

Allianz Biosciences Pvt Ltd

Form

Dry Syrup

Composition

Pre & Probiotic

Key Ingredients

Each 5ml of BIFILAC Dry Syrup contains 

  • Streptococcus faecalis T-110 JPC - 30 million 
  • Clostridium butyricum TO-A - 2 million 
  • Bacillus mesentericus TO-A - 1 million 
  • Lactic acid bacillus (Lactobacillus sporogenes) - 50 million 

Description

BIFILAC contains, Streptococcus faecalis T-110, Clostridium butyricum TO-A, Bacillus mesentericus TO-A which are patented strains, licensed from TOA Pharmaceuticals Co. ltd, Japan and Lactic acid bacillus (Lactobacillus sporogenes), which is a time tested probiotic strain. Through their symbiotic action they produce certain pathogen (Bad bacteria) inhibiting factors and in addition also produce a bifidogenic nutrient which helps in increasing the count of beneficial bacteria in the intestine. 

Get more details